A2 Milk, which reported a massive eighty-fold increase in half-year profit yesterday, is well-placed to weather ongoing regulatory changes in China's infant formula market, says managing director Geoff Babidge.
Shares in the alternative dairy firm soared to an intra-day record of $2.60 yesterday after the firm reported the interim profit surge and boosted earnings guidance for the full-year on the back of rapidly growing sales of its Platinum baby milk brand in the Chinese and Australasian markets.
The stock, which was the best performer on the S&P/NZX50 last year, then lost ground to finish the day up 3.45 per cent at $2.10. Profit for the six months to December 31 rose to $10.1 million from $125,000 in the same period a year earlier.
A2 lifted guidance for full-year operating earnings before income, tax, depreciation, and amortisation (ebitda) of $45 million to $49 million, up from a previous forecast range of $33 million to $37 million.
Infant formula revenue in Australia, New Zealand and China rose to $73.9 million in the half-year period, a 340 per cent increase on the prior comparable period.